BioSpace News Archive

Business

EmCyte Corporation® launches a not for profit training organization Gulf Coast Biologics, Inc.

The center provides scientific education and training for regenerative medicine

March 6, 2019
·
2 min read
Biotech Beach

Tandem Diabetes Care Announces Upcoming Conference Presentations - March 6, 2019

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that John Sheridan, president and chief executive officer, will present at the following upcoming investor conferences

March 6, 2019
·
1 min read
Deals

Hill-Rom Raises Quarterly Dividend payable on March 29, 2019

Hill-Rom Holdings, Inc., announced that its board of directors declared a 5 percent increase in the company’s quarterly dividend rate, from the previous rate of $0.20 per share to $0.21 per share.

March 6, 2019
·
1 min read
Business

Zymeworks Reports 2018 Year-End Financial Results

Zymeworks Inc., a clinical-stage biopharmaceutical company developing multifunctional therapeutics, reported financial results for the year ended December 31, 2018.

March 6, 2019
·
11 min read
Biotech Bay

Gilead Presents Data on Biktarvy® (Bictegravir, Emtricitabine and Tenofovir Alafenamide) in Virologically Suppressed Adults, Including Those With Pre-Existing NRTI Resistance

Gilead Sciences, Inc. announced data from two studies evaluating the resistance profile of Biktarvy® in virologically suppressed adults switching from dolutegravir/abacavir/lamivudine or a boosted protease inhibitor-based regimen for the treatment of HIV-1.

March 6, 2019
·
9 min read
Biotech Bay

HelloMD Extends HIPAA Compliant Video Chats, Between Cannabis Patients and Doctors, to all 50 States

Having connected more than 100,000 cannabis patients to doctors and nurse practitioners in California, New York, and Canada via online video, HelloMD now says “Hello!” to canna-curious patients nationwide.

March 6, 2019
·
3 min read
Deals

Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock - March 7, 2019

Epizyme, Inc. today announced the pricing of two concurrent underwritten public offerings of (i) 10,000,000 shares of its common stock and (ii) 304,348 shares of its non-voting Series A Convertible Preferred Stock.

March 6, 2019
·
5 min read
Business

Exactech Knees Deliver Excellent Results

Scientific Studies Demonstrate Exactech Knee System’s Positive Outcomes, User Experience and Accuracy

March 6, 2019
·
3 min read
Biotech Beach

New Data From Amgen To Be Presented At ACC.19 Continues To Build Evidence For Repatha® (evolocumab) Across Multiple Patient Populations

Several Real-World Evidence Studies Highlight Continued Unmet Need and Suboptimal Treatment of High-Risk Cardiovascular Disease Patients

March 6, 2019
·
21 min read
Biotech Bay

Sangamo Therapeutics Announces Participation At Upcoming Investor Conferences

Sangamo Therapeutics, Inc., a genomic medicine company, announced that management will participate in the following healthcare investor conferences in March

March 6, 2019
·
1 min read